The 18th International Conference on Human Retrovirology: HTLV and Related Viruses will take place March 7-10, 2017 in Tokyo, Japan. The International Retrovirology Association (IRVA) holds the conference once every two years in various locations around the world. This will be the first time Japan is hosting since 2007, when the 13th conference convened among the beautiful natural scenery in Hakone nearly a decade ago.
This conference represents an important opportunity for HTLV and related viruses researchers from across the globe to assemble and share their knowledge and experience. The leaders of the field announce their latest findings and casually exchange ideas on everything from basic experiments to clinical trials. This kind of international collaboration drives medical research and drug development for the HTLV-1-associated diseases plaguing the world, namely adult T-cell leukemia/lymphoma (ATLL), HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), and HTLV-1-associated uveitis. A multitude of researchers, clinicians, and students gather together as colleagues and friends regardless of nationality, creating an ideal environment for advancing research through international collaboration.
We are inspired by the hope that our efforts may relieve the suffering of patients even a single day sooner. In recent years, as progress quickens in the field of HTLV research, we have begun to see the fruits of our labors, discovering mechanisms underlying the diseases as well as developing novel treatments. And now, to open the door to a new range of discoveries, we are announcing that the theme of this year’s conference will be “The New Phase of HTLV Research.”
We look forward to welcoming all of you to Tokyo, where the classic and modern coexist. Although Tokyo has maintained strong ties to traditional Japanese culture, it is also a technologically advanced modern city, home to the famous Tokyo Skytree, the tallest radio tower in the world.
Finally, I would like to say that I am honored to be appointed as the facilitator for this year’s conference. I humbly accept the important task of serving the HTLV research representatives of the world. I will strive whole-heartedly to conduct our conference smoothly and create an enjoyable experience that all who attend will remember fondly.
Dr. Yoshihisa Yamano, MD PhD
Organizing Committee Chairman
18th International Conference on Human Retrovirology: HTLV and Related Viruses